GWW
46
-2
ED
45
2
WM
60
-4
DD
38
-2
WHR
57
7
FITB
59
3
ICE
57
-3
A
44
-2
NOV
37
-2
UPS
40
12
SWKS
42
2
HSY
38
6
MMM
52
2
KR
59
2
KEY
53
12
GOOG
59
-6
MMC
53
2
URI
56
4
EBAY
62
9
WBA
35
-3
GWW
46
-2
ED
45
2
WM
60
-4
DD
38
-2
WHR
57
7
FITB
59
3
ICE
57
-3
A
44
-2
NOV
37
-2
UPS
40
12
SWKS
42
2
HSY
38
6
MMM
52
2
KR
59
2
KEY
53
12
GOOG
59
-6
MMC
53
2
URI
56
4
EBAY
62
9
WBA
35
-3
Financhill
Back

The Bancorp Vs. Apellis Pharmaceuticals Industry Stock Comparison

Buy
63

TBBK
The Bancorp

Last Price:
$51.08
Seasonality Move:
-2.95%
Sell
34

APLS
Apellis Pharmaceuticals

Last Price:
$17.70
Seasonality Move:
-9.52%
Buy
63
The Bancorp (TBBK) is a Buy

Is The Bancorp a Buy, Sell or Hold?

  • The current The Bancorp [TBBK] share price is $51.07. The Score for TBBK is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
  • TBBK is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
34
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $17.69. The Score for APLS is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

TBBK Stock Price Chart

What is The Bancorp's stock price today?

  • The The Bancorp share price today is $51.07
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TBBK is experiencing slight buying pressure.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $17.69
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

TBBK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.14 Sell
Relative Strength Index (14 RSI): 48.64 Sell
Chaikin Money Flow: 185612 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (50.34 - 53.36) Sell
Bollinger Bands (100): (47.95 - 57.55) Sell

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.08 Sell
Relative Strength Index (14 RSI): 42.98 Sell
Chaikin Money Flow: -561522 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (17.2 - 19.06) Sell
Bollinger Bands (100): (17.72 - 26.54) Sell

TBBK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 51.46 Sell
20-day SMA: 51.39 Sell
50-day SMA: 50.32 Buy
200-day SMA: 53.2 Sell
8-day EMA: 51.06 Buy
20-day EMA: 51.37 Sell
50-day EMA: 51.41 Sell
200-day EMA: 50.81 Buy

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 18.56 Sell
20-day SMA: 18.3 Sell
50-day SMA: 18.27 Sell
200-day SMA: 26.83 Sell
8-day EMA: 18.25 Sell
20-day EMA: 18.36 Sell
50-day EMA: 19.23 Sell
200-day EMA: 26.97 Sell

The Bancorp Earnings Growth & TBBK Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.23 per share, an increase next quarter of $0.21 per share, an increase this year of $0.96 per share, and an increase next year of $1.25 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.11 per share, an increase next quarter of $0.18 per share, a decrease this year of $0.14 per share, and an increase next year of $1.12 per share.

The Bancorp Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):